-
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants
Cobelens, F., Pelzer, P. T., Churchyard, G. J., Garcia-Basteiro, A., Hatherill, M., Hill, P. C., Martinez, L. & White, R. G., 13 Aug 2025, In: Vaccine. 61, 127301.Research output: Contribution to journal › Article* › Academic › peer-review
-
Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials
White, R. G., Churchyard, G. J., Horton, K. C., Fiore-Gartland, A., Behr, M. A., Clark, R. A., Cobelens, F., Ernst, J. D., Esmail, H., Garcia-Basteiro, A. L., Hadinegoro, S. R., Hanekom, W. A., Hatherill, M., Hill, P. C., Muloiwa, R., Pelzer, P. T., Rangaka, L., Rees, H., Schrager, L. & Stanley, M. & 3 others, , 2025, (E-pub ahead of print) In: The Lancet Respiratory Medicine.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data
Pelzer, P. T., Stuck, L., Martinez, L., Richards, A. S., Acuña-Villaorduña, C., Aronson, N. E., Bonnet, M., Carvalho, A. C., Chan, P.-C., Huang, L.-M., Fang, C.-T., Churchyard, G., Corral-Londoño, H. D., Datta, M., Espinal, M. A., Fielding, K., Fiore-Gartland, A. J., Garcia-Basteiro, A., Hanekom, W. & Hatherill, M. & 22 others, , 19 Dec 2024, (E-pub ahead of print) In: The Lancet Microbe. 100961.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
